Organ Preservation in Rectal Cancer by Dose Escalated MR Guided Adaptive Radiotherapy
A phase 2 trial of MR-guided adaptive radiotherapy in Rectal cancer, run by University Hospital Tuebingen, now recruiting.
Overview
Organ Preservation in Rectal Cancer by Dose Escalated MR Guided Adaptive Radiotherapy is a phase 2 interventional study registered as NCT07337876 by University Hospital Tuebingen, with 100 participants planned, started 2026-01-07 and due to reach its primary completion in 2029-01. Interventions recorded: Dose escalated radiotherapy using a 1.5 T MR-Linac. Conditions recorded: Rectal Cancer.
Linked to the technology MR-guided adaptive radiotherapy because the registry's title names it ("mr guided adaptive radiotherapy") and Rectal cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialMR-guided Adaptive Radiotherapy Combined With PD-1 Antibody and CAPOX for Locally Advanced Rectal Cancer
Shares MR-guided adaptive radiotherapy, Rectal cancer and the tag pipeline.
- TrialPreoperative IMRT With Concurrent High-dose Vitamin C and mFOLFOX6 in Locally Advanced Rectal Cancer
Shares Rectal cancer and the tag pipeline.
- TrialTo Evaluate Dose and Safety of NanoEcho Particle-1 Using NanoEcho Imaging Device Examinations of Rectal Lymph Nodes in Healthy Volunteers and Rectal Cancer Patients.
Shares Rectal cancer and the tag pipeline.
- TrialAdaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
Shares Rectal cancer and the tag pipeline.
- TrialNCT + PD1 + Ketogenic Diet and/or Vitamin C for LARC
Shares Rectal cancer and the tag pipeline.
- TrialStudy of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation
Shares Rectal cancer and the tag pipeline.
- TrialA Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum
Shares Rectal cancer and the tag pipeline.
- TrialA Study of Dostarlimab in Participants With Untreated Locally Advanced Rectal Cancer in China
Shares Rectal cancer and the tag pipeline.